Filtros de búsqueda

Lista de obras de Tadeusz Robak

2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemia

artículo científico publicado en 1995

2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger

artículo científico publicado en 1999

2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia

artículo científico publicado en 1999

2-Chlorodeoxyadenosine alone and in combination with cyclophosphamide and mitoxantrone induce apoptosis in B chronic lymphocytic leukemia cells in vivo

scientific article published on 01 January 2004

2-Chlorodeoxyadenosine inhibits activity of adenosine deaminase and S-adenosylhomocysteine hydrolase in patients with chronic lymphocytic leukaemia

artículo científico publicado en 1997

2-chlorodeoxyadenosine (2-CDA)--a new antineoplastic and immunosuppressive drug

artículo científico publicado en 1992

2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cells.

artículo científico publicado en 2000

2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia

scientific article published on 01 June 1996

2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.

artículo científico publicado en 1999

2-chlorodeoxyadenosine (cladribine) induced allergic cutaneous reactions with eosinophilia in a patient with B-cell chronic lymphocytic leukemia

artículo científico publicado el 1 de enero de 1997

2‐Chlorodeoxyadenosine (cladribine)‐related eosinophilia in patients with lymphoproliferative diseases ⬇️

artículo científico publicado el 1 de octubre de 1997

A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia

artículo científico publicado en 2022

A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial

scientific article published on 28 February 2020

A Distributed International Patient Data Registry for Hairy Cell Leukemia

A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-alpha and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice

artículo científico publicado en 1994

A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma

scientific article published on 14 August 2019

A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial

scientific article published on 31 March 2020

A large single-institution retrospective analysis of aggressive B-cell lymphomas according to the 2016/2017 WHO classification

artículo científico publicado en 2019

A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG).

artículo científico publicado en 2003

A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of

scientific article published on 27 April 2005

A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma.

artículo científico publicado en 2015

A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older.

artículo científico publicado en 2009

A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relap

artículo científico publicado en 2014

Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.

artículo científico publicado en 2005

Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion: report from the Polish Adult Leukemia Group

artículo científico publicado en 2009

Activity of cladribine combined with etoposide in heavily pretreated patients with indolent lymphoid malignancies

artículo científico publicado en 2005

Acute lymphoblastic leukaemia in elderly patients: biological characteristics and therapeutic approaches

artículo científico publicado en 2004

Acute lymphoblastic leukemia in adult first manifested as severe aplastic anemia--role of molecular analysis in correct diagnosis

scientific article published on 01 May 2002

Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experience

artículo científico publicado en 2003

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

artículo científico publicado en 2004

Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.

artículo científico publicado en 2017

Additive cytotoxic effect of bortezomib in combination with anti-CD20 or anti-CD52 monoclonal antibodies on chronic lymphocytic leukemia cells

artículo científico publicado en 2006

Advances in the pharmacotherapeutic options for primary nodal peripheral T-cell lymphoma

Aggressive primary plasma cell leukemia with skin manifestations, trisomy 8 and molecular oligoclonal features

artículo científico publicado en 2002

Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia

artículo científico publicado en 2007

Alemtuzumab for B-cell chronic lymphocytic leukemia

artículo científico publicado en 2008

Alemtuzumab in the treatment of chronic lymphocytic leukemia

artículo científico publicado en 2005

Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia

artículo científico publicado en 2002

Altered expression of nuclear non-histone protein (p44/46) in different stages of B-chronic lymphocytic leukemia

Amifostine and 2-CdA: a novel purging strategy in CML autografting?

scientific article published on 01 May 2000

An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma

artículo científico publicado en 2004

Analysis of prognostic factors in acute leukemias in adults

artículo científico publicado en 1987

Angiopoietins in haematopoietic stem cell mobilisation in patients with haematological malignancies

artículo científico publicado en 2014

Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitro

artículo científico publicado en 2002

Anti-CD37 antibodies for chronic lymphocytic leukemia

artículo científico publicado en 2014

Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia

artículo científico publicado en 2016

Antigenic phenotype of the myeloid leukaemic cells defined by monoclonal antibodies

artículo científico publicado en 1987

Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice.

artículo científico publicado en 1992

Apoptotic gene expression under influence of fludarabine and cladribine in chronic lymphocytic leukemia-microarray study

artículo científico publicado en 2012

Application of hematopoietic growth factors (G-CSF and GM-CSF) in the treatment of chemotherapy-induced or idiopathic bone marrow failure

artículo científico publicado en 1993

Application of new drugs in chronic lymphocytic leukemia ⬇️

artículo científico publicado el 10 de mayo de 2010

Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study

artículo científico

Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP versus R-CHOP in the phase 3 LYM-3002 study

artículo científico publicado en 2017

Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity

artículo científico publicado en 1998

Atypical chronic myelogenous leukemia following immunosuppressive therapy for severe aplastic anemia

artículo científico publicado en 1999

Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine).

artículo científico publicado en 1997

Autoimmune thrombocytopenia: Current treatment options in adults with a focus on novel drugs

artículo científico publicado en 2019

BCR signaling in chronic lymphocytic leukemia and related inhibitors currently in clinical studies

artículo científico publicado en 2013

Bendamustine alone or with rituximab modifies expression of apoptosis-regulating genes and proteins of CLL cells, depending on IGVH mutational status

artículo científico publicado en 2018

Blockage of Wnt/β-Catenin Signaling by Nanoparticles Reduces Survival and Proliferation of CLL Cells In Vitro-Preliminary Study

artículo científico publicado en 2017

Bone lesions in hairy cell leukemia: Diagnosis and treatment

artículo científico publicado en 2020

Book review: Safety of Biologics Therapy.

artículo científico publicado en 2017

Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later

scientific article published on 01 June 2019

Bortezomib in the treatment of mantle cell lymphoma

artículo científico

Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma

artículo científico publicado en 2015

CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians.

artículo científico publicado en 2009

CLADRIBINE AS FRONTLINE TREATMENT OF HAIRY CELL LEUKEMIA: A MULTICENTER EUROPEAN EXPERIENCE OF MORE THAN 30 YEARS ON 384 PATIENTS

artículo científico publicado en 2021

Calorimetric study as a potential test for choosing treatment of B-cell chronic lymphocytic leukemia

artículo científico publicado en 2008

Caspase-mediated cell death in hematological malignancies: theoretical considerations, methods of assessment, and clinical implications

artículo científico publicado en 2003

Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium

scientific article published on 20 November 2019

Cereblon expression predicts clinical response in chronic lymphocytic leukemia treated with a thalidomide/fludarabine regimen

artículo científico publicado en 2014

Changes in leukemic cell nuclei revealed by differential scanning calorimetry.

artículo científico publicado en 2005

Changes in the apoptotic gene expression profile in CLL patients treated with rituximab combined with cladribine and cyclophosphamide-preliminary results

article

Characterization of haematological parameters with bortezomib-melphalan-prednisone versus melphalan-prednisone in newly diagnosed myeloma, with evaluation of long-term outcomes and risk of thromboembolic events with use of erythropoiesis-stimulating

artículo científico publicado en 2011

Chlorambucil for the treatment of patients with chronic lymphocytic leukaemia, or small lymphocytic lymphoma

artículo científico publicado en 2011

Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) - a systematic review and meta-analysis of randomized trials

artículo científico publicado en 2016

Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial

artículo científico

Chromosomal aberrations in chronic lymphocytic leukemia detected by conventional cytogenetics with DSP30 as a single agent: comparison with FISH

artículo científico publicado en 2011

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

artículo científico publicado en 2015

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

artículo científico publicado en 2020

Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article published on 01 September 2011

Chronic myelomonocytic leukemia coexisting with B-cell chronic lymphocytic leukemia

artículo científico publicado en 2003

Ciprofloxacin prophylaxis for patients undergoing high-dose chemotherapy and autologous stem cell transplantation (ASCT) - a single-center experience

artículo científico publicado en 2012

Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma

scientific article published on 01 May 1999

Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus

artículo científico publicado en 1999

Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia

artículo científico publicado en 2003

Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus

scientific article published on 01 January 2002

Circulating angiogenic cytokines in multiple myeloma and related disorders.

artículo científico publicado en 2003

Circulating endothelial cell kinetics and their potential predictive value during mobilization procedure.

artículo científico publicado en 2013

Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus

artículo científico publicado en 2009

Circulating endothelial cells in essential thrombocythemia and polycythemia vera: correlation with JAK2-V617F mutational status, angiogenic factors and coagulation activation markers.

artículo científico publicado en 2010

Circulating endothelial cells in patients with acute myeloid leukemia

artículo científico publicado en 2005

Circulating endothelial microparticles in patients with acute myocardial infarction

artículo científico publicado en 2005

Circulating interleukin-6 type cytokines in patients with systemic lupus erythematosus

artículo científico publicado el 1 de septiembre de 1997

Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia

artículo científico publicado en 2003

Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosus

artículo científico publicado en 2007

Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythomatosus

artículo científico publicado en 2006

Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia

artículo científico publicado en 2005

Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (

scientific article published on 21 March 2006

Cladribine as monotherapy or combined with dexamethasone and idarubicin or mitoxantrone in previously treated patients with low-grade lymphoid malignancies

scientific article published on 01 February 2000

Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia.

artículo científico publicado en 2001

Cladribine combined with cyclophosphamide and mitoxantrone is an active salvage therapy in advanced non-Hodgkin's lymphoma.

artículo científico publicado en 2007

Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia

artículo científico publicado en 2002

Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult

artículo científico publicado en 2007

Cladribine combined with mitoxantrone in the treatment of blastic phase of chronic myeloid leukemia

artículo científico publicado en 2001

Cladribine decreases the level of angiogenic factors in patients with chronic lymphocytic leukemia

artículo científico publicado en 2002

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.

artículo científico publicado en 2007

Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies.

artículo científico publicado en 2001

Cladribine in the treatment of acute myeloid leukemia

artículo científico publicado en 2014

Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients

artículo científico publicado en 2000

Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial.

artículo científico publicado en 2000

Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.

artículo científico publicado en 2012

Clinical management of mantle cell lymphoma in the elderly

scientific article published on 02 August 2019

Clinical pharmacology of a oxazaphosphorine derivative--ifosfamide

artículo científico publicado el 5 de agosto de 1991

Clinical pharmacology of cis-diamminedichloroplatinum and its value in the chemotherapy of neoplasms

artículo científico publicado el 1 de enero de 1983

Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia.

artículo científico publicado en 2014

Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus

artículo científico publicado en 2004

Clinically meaningful reduction in pruritus in patients with cutaneous T-cell lymphoma treated with romidepsin.

artículo científico publicado en 2012

Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma

artículo científico publicado en 2015

Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity

artículo científico publicado en 2009

Clonal evolution in CLL patients as detected by FISH versus chromosome banding analysis, and its clinical significance.

artículo científico publicado en 2013

Clonal proliferation of large granular lymphocytes -- LGL leukemia

artículo científico publicado el 1 de enero de 1995

Coexistence of chronic lymphocytic leukemia and essential thrombocythemia

artículo científico publicado en 2003

Combination regimen of 2-chlorodeoxyadenosine (cladribine), mitoxantrone and dexamethasone (CMD) in the treatment of refractory and recurrent low grade non-Hodgkin's lymphoma

artículo científico publicado en 1999

Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemia

artículo científico publicado en 2000

Combined cyclic treatment of generalized Hodgkin's disease by the MOPP program. Preliminary results and observed complications

artículo científico publicado el 4 de abril de 1977

Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy

artículo científico publicado en 2008

Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk

artículo científico publicado en 2011

Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study).

artículo científico publicado en 2010

Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1).

artículo científico publicado en 2005

Comparison of various diagnostic methods in assessing platelet count in patients with immune thrombocytopenia

Comparison study for genotyping of a single-nucleotide polymorphism in the tumor necrosis factor promoter gene

artículo científico publicado en 2002

Concomitance of monosomal karyotype with at least 5 chromosomal abnormalities is associated with dismal treatment outcome of AML patients with complex karyotype - retrospective analysis of Polish Adult Leukemia Group (PALG).

artículo científico publicado en 2016

Concurrent treatment with two B-cell receptor pathway inhibitors

artículo científico publicado en 2018

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

artículo científico publicado en 2016

Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patients

artículo científico publicado en 2011

Current Phase II antibody-drug conjugates for the treatment of lymphoid malignancies

artículo científico publicado en 2014

Current Treatment of Refractory/Relapsed Chronic Lymphocytic Leukemia: A Focus on Novel Drugs

scientific article published on 25 November 2020

Current and emerging monoclonal antibody treatments for chronic lymphocytic leukemia: state of the art.

artículo científico publicado en 2014

Current and emerging therapies for acute myeloid leukemia

scientific article published on January 2009

Current and emerging treatments for chronic lymphocytic leukaemia

artículo científico publicado en 2009

Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.

artículo científico publicado en 2009

Current treatment options in hairy cell leukemia and hairy cell leukemia variant

artículo científico publicado en 2006

Current treatment options in prolymphocytic leukemia.

artículo científico publicado en 2007

Cutaneous leukocytoclastic vasculitis at diagnosis of hairy cell leukemia successfully treated with vemurafenib and rituximab

artículo científico publicado en 2021

Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib

scientific article published on 06 June 2020

Cytokines in rheumatoid arthritis

artículo científico publicado en 1997

Cytokines serum levels as the markers of thyroid activation in Graves' disease

scientific article published on 01 February 1998

Cytotoxic activity of the amphibian ribonucleases onconase and r-amphinase on tumor cells from B cell lymphoproliferative disorders

artículo científico publicado en 2014

Cytotoxic activity of the selected pyridinium salts against murine leukemia L1210

artículo científico publicado en 2007

Cytotoxic and apoptosis-inducing effects of bendamustine used alone and in combination with rituximab on chronic lymphocytic leukemia cells in vitro

scientific article published on 05 December 2014

Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells

artículo científico publicado en 2006

Cytotoxic effect of cyclosporin A alone and in combination with 2-chlorodeoxyadenosine against P388 murine leukemia in vivo.

artículo científico publicado en 2002

Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial.

artículo científico publicado en 2007

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION).

artículo científico publicado en 2011

Dealing with hypodysfibrinogenemia during pregnancy with a successful outcome

Decitabine improves response rate and prolongs progression-free survival in older patients with newly diagnosed acute myeloid leukemia and with monosomal karyotype: A subgroup analysis of the DACO-016 trial

artículo científico publicado en 2018

Depsipeptide (FK228) as a novel histone deacetylase inhibitor: mechanism of action and anticancer activity

artículo científico publicado en 2007

Der Stand der Therapie bei der refraktären/rezidivierenden chronischen lymphatischen Leukämie: Neuartige Wirkstoffe im Fokus

Detection of P53 mutations in different cancer types is improved by cDNA sequencing.

artículo científico publicado en 2010

Determination of the in vivo effects of cladribine alone and its combination with cyclophosphamide or cyclophosphamide and mitoxantrone on Bax and Bcl-2 protein expression in B-CLL cells

artículo científico publicado en 2004

Diagnostic and therapeutic quandaries in primary manifestation of Hodgkin's disease in the central nervous system.

artículo científico publicado en 2002

Different prognosis of acute myeloid leukemia harboring monosomal karyotype with total or partial monosomies determined by FISH: retrospective PALG study.

artículo científico publicado en 2012

Disseminated superficial actinic porokeratosis in a patient with systemic lupus erythematosus

artículo científico publicado en 1999

Distinct Activities of Glycolytic Enzymes Identify Chronic Lymphocytic Leukemia Patients with a more Aggressive Course and Resistance to Chemo-Immunotherapy.

artículo científico publicado en 2018

Distribution and clinical significance of blood dendritic cells in children with juvenile idiopathic arthritis

scientific article published on 26 October 2007

Distribution of allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population

scientific article published on 01 September 2002

Do polymorphisms in ABC transporter genes influence risk of childhood acute lymphoblastic leukemia?

artículo científico publicado en 2008

Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?

artículo científico publicado en 2001

Donor age and C1orf132/MIR29B2C determine age-related methylation signature of blood after allogeneic hematopoietic stem cell transplantation.

artículo científico publicado en 2016

Drug resistance in multiple myeloma

scientific article published on 04 September 2018

Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma

artículo científico publicado en 2019

Early effects of treatment with radium and cobalt-60 gamma radiation on the proportions and absolute counts of T and B lymphocytes in peripheral blood of women with cervical carcinoma

artículo científico publicado el 1 de julio de 1977

Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)

scientific article published on 29 October 2019

Editorial : novel and emerging drugs for leukemias

scientific article published on 01 June 2012

Effect of FCGR2A and FCGR3A variants on CLL outcome

artículo científico publicado en 2010

Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia.

artículo científico publicado en 1999

Effect of childhood splenectomy on the changes in various indicators of immunological reactivity and cyclic AMP concentration in lymphocytes

artículo científico publicado el 1 de enero de 1983

Effect of granulocyte-macrophage colony stimulating factor and granulocyte colony stimulating factor on melatonin secretion in rats in vivo and in vitro studies

artículo científico publicado en 1995

Effect of granulocyte-macrophage colony stimulating factor and granulocyte colony stimulating factor on prolactin and adrenocorticotropic hormone secretion in rats: dose- and time-response in vivo studies

artículo científico publicado en 1996

Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction

artículo científico publicado en 2009

Effect of lithium on the hematopoietic stem cells

artículo científico publicado en 1989

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

scientific article published on 01 January 1992

Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine

scientific article published on 20 November 2012

Efficacy and safety of B-cell receptor signaling pathway inhibitors in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis of randomized clinical trials.

artículo científico publicado en 2017

Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura

artículo científico publicado en 2009

Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia

artículo científico publicado en 2010

Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the rand

artículo científico publicado en 2018

Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial

artículo científico publicado en 2017

Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpura

artículo científico publicado en 2007

Efficacy and safety of pegylated liposomal Doxorubicin in combination with bortezomib for multiple myeloma: effects of adverse prognostic factors on outcome.

artículo científico publicado en 2011

Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG)

artículo científico publicado en 2017

Efficacy and toxicity of low-dose melphalan in myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia

scientific article published on 01 January 2003

Efficacy of lomustine, teniposide, doxorubicin, bleomycin and prednisone (LTABP) or adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) in the treatment of malignant lymphogranulomatosis resistant to MOPP

artículo científico publicado el 21 de mayo de 1990

Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma

artículo científico publicado en 2006

Elevated plasma levels of the angiogenic tetrapeptide acetyl-ser-asp-lys-pro are found in some patients with hematologic malignancies

artículo científico publicado en 2009

Emerging antibody-drug conjugates for treating lymphoid malignancies

artículo científico

Emerging drugs for rarer chronic lymphoid leukemias

artículo científico publicado en 2008

Emerging immunological drugs for chronic lymphocytic leukemia

artículo científico

Emerging monoclonal antibodies and related agents for the treatment of chronic lymphocytic leukemia

artículo científico

Erratum to: Donor age and C1orf132/MIR29B2C determine age-related methylation signature of blood after allogeneic hematopoietic stem cell transplantation.

artículo científico publicado en 2016

Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia

artículo científico publicado en 2002

Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia

artículo científico publicado en 2009

Experimental methods used in the evaluation of antitumor action of new agents

artículo científico publicado el 1 de mayo de 1978

Exposure to low doses of solar-simulated radiation induces an increase in the myeloid subtype of blood dendritic cells

artículo científico publicado en 2004

Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia

artículo científico publicado en 2010

Expression of gene encoding P65 oncofetal protein in acute and chronic leukemias

artículo científico publicado en 2002

Expression of p21 and MDM-2 proteins on tumor cells in responding and non-responding patients with Hodgkin's disease.

artículo científico publicado en 1999

Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.

artículo científico publicado en 1998

Expression of the multidrug resistance-associated protein (mrp) gene in chronic lymphocytic leukemia

artículo científico publicado en 2002

Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus

artículo científico publicado en 2014

Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma.

artículo científico publicado en 2016

Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma

artículo científico publicado en 2010

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial

artículo científico publicado en 2008

Forodesine (BCX-1777, Immucillin H)--a new purine nucleoside analogue: mechanism of action and potential clinical application

artículo científico publicado en 2007

Front-line treatment of CLL in the era of novel agents

artículo científico publicado en 2016

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymp

artículo científico publicado en 2018

Fulminant 2-chlorodeoxyadenosine-related peripheral neuropathy in a patient with paraneoplastic neurological syndrome associated with lymphoma.

artículo científico publicado en 1996

Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia.

artículo científico publicado en 2004

G-CSF administered in time-sequenced setting during remission induction and consolidation therapy of adult acute lymphoblastic leukemia has beneficial influence on early recovery and possibly improves long-term outcome: a randomized multicenter stud

scientific article published on 01 February 2002

GA-101, a third-generation, humanized and glyco-engineered anti-CD20 mAb for the treatment of B-cell lymphoid malignancies

artículo científico publicado en 2009

Gene expression of INPP5F as an independent prognostic marker in fludarabine-based therapy of chronic lymphocytic leukemia

artículo científico publicado en 2015

Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results

artículo científico publicado en 2018

Glasdegib in the treatment of acute myeloid leukemia

scientific article published on 21 August 2019

Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays

artículo científico publicado en 2016

Guidelines for diagnosis, indications for treatment, response assessment and supportive management of chronic lymphocytic leukemia.

artículo científico publicado en 2018

HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2015

Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

artículo científico publicado en 2015

Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

artículo científico publicado en 2021

Hairy cell leukemia-variant treated with 2-chlorodeoxyadenosine--a report of three cases

artículo científico publicado en 1997

Hairy cell leukemia: a brief update on current knowledge and treatment prospects

artículo científico publicado en 2021

Hairy-cell leukemia variant: recent view on diagnosis, biology and treatment

artículo científico publicado en 2010

Health-related quality of life and patient-reported outcomes of ofatumumab plus fludarabine and cyclophosphamide versus fludarabine and cyclophosphamide in the COMPLEMENT 2 trial of patients with relapsed CLL.

artículo científico publicado en 2016

Hematologic problems in systemic lupus erythematosus

artículo científico publicado el 1 de enero de 1995

High activity of rituximab combined with cladribine and cyclophosphamide in a patient with pulmonary lymphomatoid granulomatosis and bone marrow involvement

scientific article published on 01 August 2006

High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment ⬇️

artículo científico publicado el 1 de agosto de 2003

High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group.

artículo científico publicado en 2002

High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies

scientific article published on 11 July 2018

Hodgkin's type of Richter's syndrome in familial chronic lymphocytic leukemia treated with cladribine and cyclophosphamide.

artículo científico publicado en 2003

How to improve the treatment outcome in chronic lymphocytic leukemia?

artículo científico publicado en 2009

Human leukocyte antigen-G polymorphisms influence the clinical outcome in diffuse large B-cell lymphoma

artículo científico publicado en 2015

Human leukocyte antigens HLA DRB1 influence clinical outcome of chronic lymphocytic leukemia?

artículo científico publicado en 2007

Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome

artículo científico publicado en 2002

Hypomethylating agents in the treatment of myelodysplastic syndromes and myeloid leukemia

scientific article published on September 2011

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia ⬇️

artículo científico publicado en 2015

Ibrutinib in chronic lymphocytic leukaemia: alone or in combination?

artículo científico publicado en 2015

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia

artículo científico publicado en 2014

Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial.

artículo científico publicado en 2019

Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2017

Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials.

artículo científico publicado en 2013

Immunoglobulins and other serum proteins, T and B lymphocytes and degree of blastic transformation of lymphocytes stimulated by PHA in the brain tumors patients

scientific article published on 01 January 1980

Impact of granulocyte colony stimulating factor administered during induction and consolidation of adults with acute lymphoblastic leukemia on survival: long-term follow-up of the Polish adult leukemia group 4-96 study

artículo científico publicado en 2009

Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL.

artículo científico publicado en 2017

Impact of intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction on left ventricular perfusion and function: a 6-month follow-up gated 99mTc-MIBI single-photon emission computed tomography study

artículo científico publicado en 2008

Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

scientific article published on 18 August 2018

Improving FCR immunochemotherapy in CLL

artículo científico publicado en 2010

Improving the treatment outcome in follicular lymphoma using rituximab maintenance

In vitro antileukemic activity of novel adenosine derivatives bearing boron cluster modification

artículo científico publicado en 2016

In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells

artículo científico publicado en 2005

In vitro cytotoxicity of ranpirnase (onconase) in combination with components of R-CHOP regimen against diffuse large B cell lymphoma (DLBCL) cell line.

artículo científico publicado en 2013

In vitro sensitivity of B-cell chronic lymphocytic leukemia to cladribine and its combinations with mafosfamide and/or mitoxantrone

artículo científico publicado en 2006

In vivo and ex vivo responses of CLL cells to purine analogs combined with alkylating agent.

artículo científico publicado en 2013

Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients.

artículo científico publicado en 2013

Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG).

artículo científico publicado en 2009

Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210

scientific article published on 01 January 1994

Influence of cladribine alone and in combination with cyclophosphamide or cyclophosphamide and mitoxantrone on bone marrow angiogenesis in chronic lymphocytic leukemia

artículo científico publicado en 2007

Influence of gemcitabine (2',2'-difluoro-deoxycytidine) and 2-chlorodeoxyadenosine on growth of normal and leukemic cells in vitro

artículo científico publicado en 2000

Influence of granulocyte-macrophage colony stimulating factor on pituitary-adrenal axis (PAA) in rats in vivo

scientific article published on 01 November 1999

Influence of high expression of Smac/DIABLO protein on the clinical outcome in acute myeloid leukemia patients

artículo científico publicado en 2010

Inheritance and clinical outcome in childhood acute lymphoblastic leukemia

artículo científico publicado en 2009

Inhibited apoptosis of synovial fluid lymphocytes in children with juvenile idiopathic arthritis is associated with increased expression of myeloid cell leukemia 1 and XIAP proteins

scientific article published on 01 August 2006

Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies

artículo científico publicado en 2011

Innovation in non-Hodgkin lymphoma drug discovery: what needs to be done?

artículo científico publicado en 2016

Interaction of 2-chlorodeoxyadenosine in combination either with interferons or recombinant human tumor necrosis factor alpha on myeloid progenitor cells in vitro

artículo científico publicado en 1996

Interaction of doxorubicin and idarubicin with red blood cells from acute myeloid leukaemia patients

artículo científico publicado en 2005

Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia

artículo científico publicado en 1996

Intracoronary administration of stem cells in patients with acute myocardial infarction - angiographic follow-up.

artículo científico publicado en 2009

Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia

artículo científico publicado en 2016

Investigational therapies targeting CD37 for the treatment of B-cell lymphoid malignancies.

artículo científico publicado en 2018

Jagged-1: a new promising factor associated with favorable prognosis in patients with acute myeloid leukemia.

artículo científico publicado en 2014

Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients

scientific article published on 11 September 2007

Lack of effect of repeated suberythemal ultraviolet-B exposures on human blood dendritic subtypes

scientific article published on 01 October 2005

Langerhans cell histiocytosis in a patient with systemic lupus erythematosus: a clonal disease responding to treatment with cladribine, and cyclophosphamide

artículo científico publicado en 2002

Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)

artículo científico publicado el 1 de octubre de 1991

Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study

artículo científico publicado en 2020

Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

artículo científico publicado en 2019

Long-term results of the Polish Adult Leukemia Group PALG-CLL2 phase III randomized study comparing cladribine-based combinations in chronic lymphocytic leukemia.

artículo científico publicado en 2013

Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies

artículo científico publicado en 2019

Low-grade non-Hodgkin's lymphoma in a patient with systemic lupus erythematosus

artículo científico publicado en 2001

Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity

artículo científico publicado en 2001

Lymphoplasmacytic lymphoma with monoclonal gammopathy-related pseudo-Gaucher cell infiltration in bone marrow and spleen--diagnostic and therapeutic dilemmas

artículo científico publicado en 2002

MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia

artículo científico publicado en 2006

MGMT promoter methylation as a potential prognostic marker for acute leukemia

artículo científico publicado en 2017

Maintenance in CLL.

artículo científico publicado en 2013

Management of Multiple Myeloma with Second-Generation Antibody-Drug Conjugates

artículo científico publicado en 2016

Management of hairy cell leukemia variant

artículo científico publicado en 2011

Mantle cell lymphoma: therapeutic options in transplant-ineligible patients

scientific article published on 25 April 2019

Mechanisms of action of the anti-VEGF monoclonal antibody bevacizumab on chronic lymphocytic leukemia cells.

artículo científico publicado en 2013

Merkel cell carcinoma in a patient with B-cell chronic lymphocytic leukemia treated with cladribine and rituximab

artículo científico publicado en 2005

MiRNA-15a, miRNA-16, miRNA-126, miRNA-146a, miRNA-223 expression in autologous hematopoietic stem cell transplantation and their impact on engraftment

artículo científico publicado en 2018

Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase I results and long-term follow-up.

artículo científico publicado en 2018

Minimizing and managing treatment-associated complications in patients with chronic lymphocytic leukemia

scientific article published on 30 November 2019

Molecular diversity of gammadelta T cells in peripheral blood from patients with B-cell chronic lymphocytic leukaemia

artículo científico publicado en 2002

Monoclonal antibodies against human T-lymphocytes

artículo científico publicado el 1 de febrero de 1983

Monoclonal antibodies in the treatment of autoimmune cytopenias

artículo científico publicado en 2004

Monoclonal antibodies in the treatment of chronic lymphoid leukemias

artículo científico publicado en 2004

Monoclonal antibodies in the treatment of systemic lupus erythematosus

artículo científico publicado en 2009

Moxetumomab Pasudotox-Tdfk in Heavily Pretreated Patients with Relapsed/Refractory Hairy Cell Leukemia (HCL): Long-Term Follow-up from the Pivotal Phase 3 Trial

artículo científico publicado en 2019

Moxetumomab pasudotox for the treatment of hairy cell leukemia

scientific article published on 10 May 2019

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

scholarly article by Robert J Kreitman et al published August 2018 in Leukemia

Multi-drug transporter MDR1 gene polymorphism and prognosis in adult acute lymphoblastic leukemia

artículo científico publicado en 2005

Multifocal osteolytic lesions in hairy cell leukemia-the importance of PET/CT in diagnosis and assessment

artículo científico publicado en 2020

Multiple myeloma in a patient with systemic lupus erythematosus, myasthenia gravis and non-familial diffuse palmoplantar keratoderma.

artículo científico publicado en 2004

New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies

artículo científico publicado el 1 de febrero de 2011

New agents in chronic lymphocytic leukemia

artículo científico publicado en 2006

New antineoplastic drugs of the podophyllotoxin derivative group

artículo científico publicado el 3 de enero de 1983

New mutation in hairy cell leukemia.

artículo científico publicado en 2015

New nucleoside analogs for patients with hematological malignancies ⬇️

artículo científico publicado el 1 de marzo de 2011

New therapeutic options for hairy cell leukemia

artículo científico publicado en 2022

No influence of 3435C>T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cells

scientific article published on 01 October 2006

Novel and emerging drugs for acute myeloid leukemia: pharmacology and therapeutic activity.

scientific article published on January 2011

Novel and emerging drugs for systemic lupus erythematosus: mechanism of action and therapeutic activity

artículo científico publicado en 2012

Novel drugs for chronic lymphoid leukemias: mechanism of action and therapeutic activity

artículo científico publicado en 2009

Novel monoclonal antibodies for the treatment of chronic lymphocytic leukemia

artículo científico publicado en 2008

Novel purine nucleoside analogues for hematological malignancies

artículo científico publicado en 2008

Novel synthetic drugs currently in clinical development for chronic lymphocytic leukemia

artículo científico publicado en 2017

Novel systemic drugs for cutaneous T-cell lymphoma

scientific article published on January 2011

Novel target to kill CLL.

artículo científico publicado en 2015

Novel therapies under investigation for mantle cell lymphoma

artículo científico publicado en 2016

Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia

artículo científico publicado en 2010

Ofatumumab for treating chronic lymphocytic leukemia: a safety profile

artículo científico publicado en 2015

Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study

artículo científico publicado en 2015

Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial.

artículo científico publicado en 2016

Ofatumumab, a human monoclonal antibody for lymphoid malignancies and autoimmune disorders

artículo científico publicado en 2008

Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies

artículo científico publicado en 2006

Older and new purine nucleoside analogs for patients with acute leukemias

artículo científico

Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients

artículo científico publicado en 2004

Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).

artículo científico publicado en 2006

Outcomes with ibrutinib by line of therapy and post-ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis

artículo científico publicado en 2019

PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia

artículo científico publicado en 2014

Pathogenesis, prophylaxis and treatment of infections in patients with chronic lymphocytic leukemia

artículo científico publicado en 2013

Pegylated liposomal doxorubicin plus bortezomib in relapsed or refractory multiple myeloma: efficacy and safety in patients with renal function impairment

artículo científico publicado en 2008

Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms

artículo científico publicado en 2006

Personalized therapy tests for the monitoring of chronic lymphocytic leukemia development

artículo científico publicado en 2017

Pharmacodynamic considerations of small molecule targeted therapy for treating B-cell malignancies in the elderly

artículo científico

Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies

artículo científico publicado en 2004

Pharmacokinetic evaluation and therapeutic activity of bendamustine in B-cell lymphoid malignancies

artículo científico publicado en 2012

Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 study

artículo científico publicado en 2010

Pharmacological and clinical studies on purine nucleoside analogs--new anticancer agents

artículo científico publicado en 2006

Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia

artículo científico publicado en 2020

Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma

artículo científico publicado en 2014

Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapse

artículo científico publicado en 2009

Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia

artículo científico publicado en 2012

Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.

artículo científico publicado en 2018

Pituitary-adrenocortical responses to the chronic administration of granulocyte colony-stimulating factor in rats

scientific article published on 01 January 2000

Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index

artículo científico publicado en 2010

Plasma levels of angiogenic factors and circulating endothelial cells in essential thrombocythemia: correlation with cytoreductive therapy and JAK2-V617F mutational status

artículo científico publicado en 2010

Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndrome

artículo científico publicado en 2001

Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases.

artículo científico publicado en 2013

Polymorphism in IKZF1 gene affects clinical outcome in diffuse large B-cell lymphoma

artículo científico publicado en 2017

Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in patients with hematological malignancies

artículo científico publicado en 2014

Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma.

artículo científico publicado en 2008

Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia

artículo científico publicado en 2012

Poor prognosis of Hodgkin variant of Richter transformation in chronic lymphocytic leukemia treated with cladribine

artículo científico publicado en 2012

Population pharmacokinetics of rituximab in patients with chronic lymphocytic leukemia

artículo científico publicado en 2012

Potential breakthroughs with investigational drugs for hairy cell leukemia

artículo científico

Preface

Preface to a supplement to Pharmacy World on the 5TH Symposium of the European Society for the Study of Purine & Pyrimidtne Metabolism in Man (ESSPPMM 1995)

Primary cutaneous marginal zone B-cell lymphoma in a patient with chronic lymphocytic leukaemia

artículo científico publicado en 2007

Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies

artículo científico publicado en 2016

Pro-apoptotic effect of an anti-CD37 scFv-Fc fusion protein, in combination with the anti-CD20 antibody, ofatumumab, on tumour cells from B-cell malignancies.

artículo científico publicado en 2014

Proapoptotic activity of alemtuzumab alone and in combination with rituximab or purine nucleoside analogues in chronic lymphocytic leukemia cells.

artículo científico publicado en 2005

Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institution

scientific article published on 01 March 2000

Prognostic value of inhibitor of apoptosis protein family expression in patients with acute myeloid leukemia.

artículo científico publicado en 2014

Prognostic value of the bone marrow microvessel density in progressive B-cell chronic lymphocytic leukemia

artículo científico publicado en 2010

Prognostic value of thymidine kinase activity in patients with chronic lymphocytic leukemia

artículo científico publicado en 2016

Proinflammatory interferon-gamma--inducing monokines (interleukin-12, interleukin-18, interleukin-15)--serum profile in patients with systemic lupus erythematosus

scientific article published on 01 July 2002

Promising anti-leukemic activity of atorvastatin.

artículo científico publicado en 2013

Proportion of B- and T-lymphocytes in lymph nodes removed from patients with Hodgkin's disease

artículo científico publicado el 1 de enero de 1978

Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribine

artículo científico publicado en 2001

Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity

artículo científico publicado en 2006

Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias

artículo científico publicado en 2012

Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications

artículo científico publicado en 2005

Purine nucleoside analogues in the treatment of myleoid leukemias

artículo científico publicado en 2003

R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase-dependent apoptosis

artículo científico publicado en 2010

Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research

artículo científico publicado en 2008

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

artículo científico publicado en 2018

Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia

artículo científico publicado en 2016

Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial).

artículo científico publicado en 2017

Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression

artículo científico publicado en 2007

Rapamycin, the mTOR kinase inhibitor, sensitizes acute myeloid leukemia cells, HL-60 cells, to the cytotoxic effect of arabinozide cytarabine

artículo científico publicado en 2009

Ratio of T and B lymphocytes in spleens of patients with malignant granulomatosis

artículo científico publicado el 1 de noviembre de 1978

Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment

artículo científico publicado en 2002

Real-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment.

artículo científico publicado en 2015

Recent clinical trials of cladribine in hematological malignancies and autoimmune disorders

artículo científico publicado en 2006

Recent progress in the management of chronic lymphocytic leukemia

artículo científico publicado en 2007

Rekomendacje diagnostyczne i terapeutyczne dla przewlekłej białaczki limfocytowej w 2014 r. – raport Grupy Roboczej PTHiT oraz PALG – CLL

Rekomendacje diagnostyczne i terapeutyczne dla przewlekłej białaczki limfocytowej w 2016 r – Raport Grupy Roboczej PTHiT i PALG-CLL

Relation of P-glycoprotein expression with spontaneous in vitro apoptosis in B-cell chronic lymphocytic leukemia

artículo científico publicado en 2004

Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma

scientific article published on 01 September 2000

Relationship between in vitro drug sensitivity and clinical response of patients to treatment in chronic lymphocytic leukemia

artículo científico publicado en 2015

Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus

artículo científico publicado en 2004

Responses to romidepsin in patients with cutaneous T-cell lymphoma and prior treatment with systemic chemotherapy.

artículo científico

Results of treating acute myeloblastic leukemia in patients over 60 years of age

artículo científico publicado el 2 de diciembre de 1991

Results of treating lymphomas with high degree of malignancy using COPP, CHOP-Bleo and MEV protocols

artículo científico publicado el 27 de septiembre de 1982

Richter syndrome first manifesting as cutaneous B-cell lymphoma clonally distinct from primary B-cell chronic lymphocytic leukaemia

artículo científico publicado en 2005

Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.

artículo científico

Richter's syndrome following cladribine therapy for chronic lymphocytic leukemia first manifested as pathologic fracture of the femur

artículo científico publicado en 2001

Richter's syndrome in the brain first manifested as an ischaemic stroke

artículo científico publicado en 2004

Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukemia treated with idelalisib

artículo científico publicado en 2020

Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter study.

artículo científico publicado en 2001

Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma

artículo científico publicado en 2006

Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies.

artículo científico publicado en 2004

Rituximab for chronic lymphocytic leukemia

artículo científico

Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia

artículo científico publicado en 2007

Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia

artículo científico publicado en 2010

Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia.

artículo científico publicado en 2010

Rituximab, cladribine and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG - CLL4 (ML21283) trial.

artículo científico publicado en 2018

Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide

artículo científico publicado en 2009

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

artículo científico publicado en 2012

Safety and Tolerability of Antibody-Drug Conjugates in Cancer

scholarly article by Anna Wolska-Washer & Tadeusz Robak published 1 February 2019 in Drug Safety

Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study

artículo científico publicado en 2008

Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine

artículo científico publicado en 2004

Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia

artículo científico publicado en 2004

Secondary leukemia

artículo científico publicado en 1992

Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission

artículo científico publicado en 1999

Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity

artículo científico publicado en 2001

Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis

artículo científico publicado en 1998

Serum tumor necrosis factor-α and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status

scientific article published on 04 September 2012

Significance of Bax expression in breast cancer patients

scientific article published on 01 October 2011

Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies

artículo científico publicado en 2018

Skin changes in hairy cell leukemia

artículo científico publicado en 2020

Skin lesions in chronic lymphocytic leukemia

artículo científico publicado en 2007

Spontaneous apoptosis of Reed-Sternberg and Hodgkin cells; clinical and pathological implications in patients with Hodgkin's disease

scientific article published on 01 September 2000

Spontaneous in vitro apoptosis of de novo chronic lymphocytic leukemia cells correlates with risk of the disease progression

artículo científico publicado en 2014

Spontaneous in vitro apoptosis of de novo chronic lymphocytic leukemia cells correlates with risk of the disease progression

artículo científico publicado en 2014

Stanowisko polskich ekspertów dotyczące zastosowania leku brentuksymab vedotin w leczeniu chorych na pierwotne chłoniaki skóry CD30+

artículo científico publicado en 2018

Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study

artículo científico publicado en 2011

Successful treatment of leukaemia cutis with cladribine in a patient with B-cell chronic lymphocytic leukaemia

artículo científico publicado en 2002

Successful treatment of refractory autoimmune thrombocytopenia with rituximab and cyclosporin A in a patient with chronic granulomatous disease.

artículo científico publicado en 2005

Survival adjusting for crossover: phase 3 study of ibrutinib vs chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma

artículo científico publicado en 2017

Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy

artículo científico publicado en 2020

Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2

artículo científico publicado en 2018

Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388

scientific article published on 01 January 1993

T and B lymphocytes in peripheral blood of patients with uterine neoplasms

artículo científico publicado el 1 de abril de 1977

T and B lymphocytes in peripheral blood of splenectomized subjects

artículo científico publicado el 1 de enero de 1976

T and B lymphocytes in the spleen of patients with Hodgkin's disease

artículo científico publicado el 1 de julio de 1976

TRU-016, a humanized anti-CD37 IgG fusion protein for the potential treatment of B-cell malignancies

artículo científico publicado en 2009

Targeted drugs in chronic myeloid leukemia.

artículo científico publicado en 2008

Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial

artículo científico publicado en 2011

The Expression of the SLIT-ROBO Family in Adult Patients with Acute Myeloid Leukemia

scientific article published on 28 February 2019

The Influence of 2-Chlorodeoxyadenosine (2-CdA) Alone and in Combination with Cyclophosphamide or Methotrexate on Normal and Leukemic Hematopoiesis ⬇️

artículo científico publicado el 1 de enero de 1994

The Influence of Imatinib Mesylate (STI571) used alone or in Combination with Purine Nucleoside Analogues on the Normal and Chronic Myelogenous Leukaemia Progenitor CellsIn Vitro ⬇️

artículo científico publicado el 1 de septiembre de 2003

The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib

The Role of Bruton’s Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions

The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients

scientific article published on 09 September 2020

The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures

artículo científico publicado en 1996

The differences in thermal profiles between normal and leukemic cells exposed to anticancer drug evaluated by differential scanning calorimetry

The discovery and development of romidepsin for the treatment of T-cell lymphoma

artículo científico publicado en 2017

The distribution and potential prognostic value of SMAD protein expression in chronic lymphocytic leukemia

artículo científico publicado en 2017

The distribution of peripheral blood dendritic cells assayed by a new panel of anti-BDCA monoclonal antibodies in healthy representatives of the polish population

scientific article published on 01 January 2004

The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemia

scientific article published on 01 December 1997

The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.

artículo científico publicado en 2003

The effect of lithium chloride on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukaemic blasts (CFU-L) in the cultures in vitro

artículo científico publicado el 1 de enero de 1991

The effect of lithium on haematopoiesis of patients with acute myeloid leukaemia

artículo científico publicado el 1 de enero de 1991

The effect of repeated exposures to low-dose UV radiation on the apoptosis of peripheral blood mononuclear cells.

artículo científico publicado en 2009

The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil.

artículo científico publicado en 2005

The efficacy of sapacitabine in treating patients with acute myeloid leukemia

artículo científico publicado en 2018

The emerging therapeutic role of antibody mixtures.

artículo científico publicado en 2013

The evaluation and optimal use of rituximab in lymphoid malignancies

The impact of agonists and antagonists of TLR3 and TLR9 on concentrations of IL-6, IL10 and sIL-2R in culture supernatants of peripheral blood mononuclear cells derived from patients with systemic lupus erythematosus

artículo científico publicado en 2017

The influence of 2- chlorodeoxyadenosine in combination with tumour necrosis factor-alpha or its mutein on murine leukaemias L1210 and P388.

artículo científico publicado en 1995

The influence of 2-chlorodeoxyadenosine alone and in combination with cyclophosphamide or methotrexate on normal hematopoiesis in mice

artículo científico publicado en 1993

The influence of amifostine used alone or in combination with 2-chlorodeoxyadenosine on normal and chronic myelogenous leukemia granulocyte-macrophage progenitor cells in vitro

scientific article published on 01 January 2000

The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro

artículo científico publicado en 2004

The influence of low molecular weight heparin on the intravascular activation of the coagulation system in patients with acute leukemia during induction chemotherapy--report of a prospective randomized study

artículo científico publicado en 2002

The influence of low-dose aspirin and hydroxyurea on platelet-leukocyte interactions in patients with essential thrombocythemia

artículo científico publicado en 2009

The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI.

artículo científico publicado en 2013

The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant

scientific article published on 10 September 2007

The influence of recombinant human tumor necrosis factor (rh-TNF alpha) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukaemic blasts (CFU-L) in cultures in vitro

artículo científico publicado el 1 de enero de 1992

The influence of recombinant human tumor necrosis factor α and its muteins used alone or in combination with 2-chlorodeoxyadenosine on normal and leukemic hematopoiesis in vitro ⬇️

artículo científico publicado el 1 de septiembre de 1997

The influence of recombinant human tumor necrosis factor-alpha, alone and in combination with cyclophosphamide or methotrexate, on leukemia L1210 and normal hematopoiesis in mice

artículo científico publicado en 1991

The inhibitor of apoptosis protein family and its antagonists in acute leukemias

artículo científico publicado en 2004

The interaction of 2-chlorodeoxyadenosine (2-CDA) and interferon alpha (IFN-alpha) on normal and myeloid leukemia hematopoiesis in vitro

scientific article published on 01 April 1994

The interaction of daunorubicin and mitoxantrone with the red blood cells of acute myeloid leukemia patients.

artículo científico publicado en 2003

The interaction of gemcitabine and cytarabine on murine leukemias L1210 or P388 and on human normal and leukemic cell growth in vitro

artículo científico publicado en 2000

The kinetics and apoptotic profile of circulating endothelial cells in autologous hematopoietic stem cell transplantation in patients with lymphoproliferative disorders

artículo científico publicado en 2013

The kinetics of hematopoietic niche cytokines and their influence on mobilization efficacy and timing in patients with hematological malignancies.

artículo científico publicado en 2014

The mammalian target of the rapamycin (mTOR) kinase pathway: its role in tumourigenesis and targeted antitumour therapy.

artículo científico publicado en 2005

The management of hematologic malignancies during the COVID-19 pandemic

artículo científico publicado en 2020

The number and distribution of blood dendritic cells in the epidermis and dermis of healthy human subjects.

artículo científico publicado en 2006

The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland

artículo científico publicado en 2004

The preclinical discovery of rituximab for the treatment of non-Hodgkin's lymphoma

artículo científico

The role of NF-κB and Smac/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patients

The role of neuronal apoptosis inhibitory protein (NAIP) in acute myeloid leukemia patients

The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies

artículo científico publicado en 2008

The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials

artículo científico publicado en 2002

The role of p73 in hematological malignancies

artículo científico publicado en 2006

The safety of available chemo-free treatments for mantle cell lymphoma

scientific article published on 18 September 2020

The safety profile of monoclonal antibodies for chronic lymphocytic leukemia

artículo científico publicado en 2016

The search for optimal treatment in relapsed and refractory acute myeloid leukemia

artículo científico publicado en 2002

The treatment of acute myeloid leukemia with mitoxantrone, etoposide and low-dose cytarabine in elderly patients - a report of Polish Acute Leukemia Group (PALG) phase II study.

artículo científico publicado en 2002

The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.

artículo científico publicado en 1998

The up-to-date role of biologics for the treatment of chronic lymphocytic leukemia

artículo científico publicado en 2020

The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literature

artículo científico publicado en 2011

Therapeutic controversies in Hodgkin's disease

artículo científico publicado en 1983

Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies

artículo científico publicado en 2005

Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies

artículo científico publicado en 2005

Thrombocytopenia during pregnancy

artículo científico publicado en 1994

Thrombotic thrombocytopenic purpura successfully treated with plasma exchange

artículo científico publicado en 1996

Toll-like receptors and their role in carcinogenesis and anti-tumor treatment.

artículo científico publicado en 2008

Toll-like receptors and their role in hematologic malignancies

artículo científico publicado en 2009

Toward personalized therapy for chronic lymphocytic leukemia: DSC and cDNA microarray assessment of two cases

artículo científico publicado en 2012

Toxic epidermal necrolysis in a patient with severe aplastic anemia treated with cyclosporin A and G-CSF.

artículo científico publicado en 2001

Transient eosinophilia in a patient with hairy-cell leukaemia treated with 2-chlorodeoxyadenosine

artículo científico publicado en 1992

Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy.

artículo científico publicado en 2004

Treatment of chemotherapy-induced or idiopathic bone marrow aplasia with granulocyte colony-stimulating factor (G-CSF)

artículo científico publicado en 1994

Treatment of drug-induced agranulocytosis with colony stimulating factors (G-CSF or GM-CSF)

artículo científico publicado en 1996

Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study

scientific article published on 21 January 2015

Treatment of patients with hairy cell leukemia with 2-chloro-2'-deoxyadenosine (2-CdA)

scientific article published on 01 January 1994

Treatment options for mantle cell lymphoma.

artículo científico

Tumour necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6) and their soluble receptors (sTNF-alpha-Rp55 and slL-6R) serum levels in systemic lupus erythematodes.

artículo científico publicado en 1996

Type of serum influences the rituximab dependent cytotoxicity and apoptosis of chronic lymphocytic leukemia cells in vitro

artículo científico publicado en 2012

Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders

artículo científico

Updated Efficacy and Safety from the Phase 3 Resonate-2 Study: Ibrutinib As First-Line Treatment Option in Patients 65 Years and Older with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia

Scientific article published on 2 Dec 2016

VEGF, ANGPT1, ANGPT2, and MMP-9 expression in the autologous hematopoietic stem cell transplantation and its impact on the time to engraftment.

artículo científico publicado en 2017

Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus

artículo científico publicado en 2003

Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox

artículo científico publicado en 2021

Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study

artículo científico publicado en 2020

Venetoclax in the treatment of chronic lymphocytic leukemia

artículo científico publicado en 2019

Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.

artículo científico publicado en 2018

Will combination therapy with targeted drugs be better for achieving remission in chronic lymphocytic leukemia?

artículo científico publicado en 2017

Wpływ skojarzonego działania bendamustyny i rytuksymabu na apoptozę i nekrozę komórek przewlekłej białaczki limfocytowej w hodowli in vitro

Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2015

artículo científico publicado en 2015

Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2016

artículo científico publicado en 2016

Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2017

artículo científico publicado en 2017

Zanubrutinib monotherapy for patients with treatment naïve chronic lymphocytic leukemia and 17p deletion

artículo científico publicado en 2020

[Adenosine deaminase (ADA), 5'-nucleotidase (5'N) and purine nucleoside phosphorylase (PNP) in lympho- and myeloproliferative disorders]

scientific article published on 01 January 1994

[Advances and controversies in the treatment of myeloblastic leukemia]

scientific article published on 01 October 1983

[Apoptosis--programmed cell death]

artículo científico publicado en 1994

[Autologous bone marrow transplantation]

scientific article published on 01 April 1987

[Autologous hematopoietic stem cell transplantation for the treatment of aggressive non-Hodgkin's lymphoma. The experience of Polish lymphoma research group]

artículo científico publicado en 2003

[Biological properties and clinical application of filgrastim (G-CSF)]

artículo científico publicado en 1993

[Biological properties and clinical significance of interleukins 12 (IL-12)]

artículo científico publicado en 1998

[Biology and clinical aspects of primary myelodysplastic syndromes]

scientific article published on 01 February 1988

[Biology and clinical pharmacology of tumor necrosis factor alpha]

artículo científico publicado en 1997

[Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine)]

artículo científico publicado en 1996

[Clinical pharmacology of hydroxyurea]

artículo científico publicado en 1995

[Clinical use of cultured clonogenic leukemia cells in vitro in acute myeloid leukemia with particular reference to drug sensitivity]

artículo científico publicado en 1989

[Current views on pathogenesis and treatment of anemia in rheumatoid arthritis]

scientific article published on 01 January 1994

[Current views on the pathogenesis and treatment of aplastic anemia]

artículo científico publicado en 1988

[Cytokines in multiple myeloma]

artículo científico publicado en 1998

[Cytokines in systemic lupus erythematosus]

artículo científico publicado en 1996

[Effect of splenectomy on hematological tolerance and the results of chemotherapy in Hodgkin's disease]

artículo científico publicado en 1982

[Hypereosinophilic syndrome and eosinophilic leukemia]

artículo científico publicado en 1995

[Infections after splenectomy]

scientific article published on 01 August 1981

[Large doses of cytarabine, etoposide and methotrexate (CEM protocol) in the treatment of lymphoblastic leukemia in adults, resistant to conventional treatment, and of recurrences]

artículo científico publicado en 1988

[Prognostic value of peripheral blood T-lymphocyte count in lymphocytic leukemia]

scientific article published on 01 January 1980

[Results of combined treatment of advanced forms of multiple myeloma with vincristine, melphalan, cyclophosphamide and prednisone (VMCP) and with vincristine, doxorubicin, cyclophosphamide and prednisone (VDCP)]

artículo científico publicado en 1983

[Results of complex treatment of adults with myeloblastic leukemia]

artículo científico publicado en 1980

[Role of the spleen in immunological processes]

scientific article published on 01 November 1980

[Surface markers of the lymphoid cells in non-Hodgkin's lymphoma]

artículo científico publicado en 1980

[The role of HLA DRB1 genetic polymorphisms in non-Hodgkin's lymphomas]

artículo científico publicado en 2005

[The role of genetic polymorphisms within tumor necrosis factor promoter gene in non-Hodgkin's lymphomas]

scientific article published on 01 January 2005

[Therapeutic problems during pregnancy and delivery in two women with aplastic anemia]

scientific article published on 01 January 1993

[Treatment of acute leukemias in adults. IV. Treatment results on 375 patients at 9 hematology centers]

scientific article published on 01 July 1981

[Treatment of acute myelogenous leukemia in elderly patients]

artículo científico publicado en 2001

[Tyrosine kinase inhibitors in the therapy of chronic myeloid leukaemia]

scientific article published on 01 January 2006

[Use of lomustine, teniposide, procarbazine and prednisone (LTPP) in the treatment of terminal-state Hodgkin's disease]

artículo científico publicado en 1986

appendix 6: Chronic lymphocytic leukaemia: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Haematological-Malignancies).

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda